No Detail Found!

Prevalence of Cardiovascular Drugs Among Pregnant Women in Sudan

Author(s)
HAJ ELAMIN. E. AZHARI Karary University, Khartoum University& Military Hospitals,Sudan
SIDDIQA M. A. HAMZA Umm Alqura University Algunfuda,Saudi Arabia
MOHAMMED. R.R Omdurman Islamic University,Sudan
H. E. OMER Fellowship of Sudan medical specialization board, Khartoum Teaching Hospital,Sudan
A. M. IMAN Omdurman Islamic University,Sudan
ENTESAR MOHAMMED ABDULLA TABEIN College of Applied Medical Sciences, Shaqra University,Saudi Arabia
HADEIL M. E. IDRIS College of Applied Medical Sciences, Shaqra University,Saudi Arabia
Abstract
Pregnant women with heart disease present multiple medical dilemmas. Pregnancy-related physiological changes impair the heart's ability to respond to pathological processes such as hypertension and heart failure. Aim: The current study's aim is to elicit data on cardiovascular medication use during pregnancy. Methods: This is a descriptive, retrospective, cross-sectional, hospital-based study, carried out in Military Hospitals and Khartoum Teaching Hospital, in Sudan. A data collection form was utilized to gather information from 650 patient files of pregnant women. Results: 650 subjects met the study criteria; 7% of women (N=46) were dispensed cardiovascular medications, the consumption being significantly higher in the third trimester (7-9 months) in 78.26% (p<0.05). The most common cardiovascular drugs dispensed were Methyldopa (N=26, 4.0%), Heparin (N=9, 1.3%), Nifedipine (N=7, 1.0%), Hydralazine (N=2, 0.3%) and Diazepam (N=2, 0.3%). Methyldopa is the commonest in the all trimesters - first (1-3 months) (N=2, 0.3%), second (4-6 months) (N=4, 0.6%) and third (7-9 months) (N=20, 3.0%). Nifedipine and Diazepam were used only in the third trimester. Conclusions: There are many clinical situations requiring cardiovascular medications in pregnancy. Thus, it is necessary to conduct frequent health educational programs educating pregnant women about the risk factors for pregnancy-induced cardiovascular disease, and proper use of medication.
Publication Details
Page(s) 676-679
Published Journal: Pakistan Journal of Medical and Health Sciences, Volume: 16, Issue: 3, Year: 2022

Request the full text from PASTIC

Keywords
Hypertension, methyldopa, Pregnant women, Cardiovascular Medications
0

Citations

0

Downloads

73

Views